UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Polyclonal hyper immunoglobulin: A proven treatment and prophylaxis platform for passive immunization to address existing and emerging diseases

Human vaccines & immunotherapeutics, 2022-04, Vol.18 (2), p.1886560-1886560

2022

Volltextzugriff (PDF)

Mature Pseudomonas aeruginosa Biofilms Prevail Compared to Young Biofilms in the Presence of Ceftazidime

Antimicrobial Agents and Chemotherapy, 2012-09, Vol.56 (9), p.4976-4979

2012

Volltextzugriff (PDF)

A novel in vitro co-culture system allows the concurrent analysis of mature biofilm and planktonic bacteria with human lung epithelia

Journal of microbiological methods, 2014-06, Vol.101, p.49-55

2014

Volltextzugriff (PDF)

Novel Clostridium difficile Anti-Toxin (TcdA and TcdB) Humanized Monoclonal Antibodies Demonstrate In Vitro Neutralization across a Broad Spectrum of Clinical Strains and In Vivo Potency in a Hamster Spore Challenge Model

PloS one, 2016-06, Vol.11 (6), p.e0157970-e0157970

2016

Volltextzugriff (PDF)

Characterization of IXINITY^® (Trenonacog Alfa), a Recombinant Factor IX with Primary Sequence Corresponding to the Threonine-148 Polymorph

Advances in Hematology, 2016, Vol.2016 (2016), p.124-132

2016

Volltextzugriff (PDF)

Angiotensin II Activates Phosphatidylinositol 3-Kinase in Vascular Smooth Muscle Cells

Circulation research, 1997-08, Vol.81 (2), p.249-257

1997

Volltextzugriff (PDF)

Modulation of the Local Neutrophil Response by a Novel Hyaluronic Acid-Binding Peptide Reduces Bacterial Burden during Staphylococcal Wound Infection

Infection and Immunity, 2010-10, Vol.78 (10), p.4176-4186

2010

Volltextzugriff (PDF)

Meta-iodobenzylguanidine, an inhibitor of arginine-dependent mono(ADP-ribosyl)ation, prevents neointimal hyperplasia

The Journal of pharmacology and experimental therapeutics, 2008-09, Vol.326 (3), p.717-724

2008

Volltextzugriff (PDF)

Both AT₁ and AT₂ receptors mediate proliferation and migration of porcine vascular smooth muscle cells

American journal of physiology. Heart and circulatory physiology, 2011-09, Vol.301 (3), p.H746-H756

2011

Volltextzugriff (PDF)

Both AT^sub 1^ and AT^sub 2^ receptors mediate proliferation and migration of porcine vascular smooth muscle cells

American journal of physiology. Heart and circulatory physiology, 2011-09, Vol.301 (3), p.H746

2011

Volltextzugriff (PDF)

Both AT 1 and AT 2 receptors mediate proliferation and migration of porcine vascular smooth muscle cells

American journal of physiology. Heart and circulatory physiology, 2011-09, Vol.301 (3), p.H746-H756

2011

Volltextzugriff (PDF)

Both AT1 and AT2 receptors mediate proliferation and migration of porcine vascular smooth muscle cells

American journal of physiology. Heart and circulatory physiology, 2011, Vol.70 (3)

2011

Volltextzugriff (PDF)

O1‐05‐04: An amyloid‐beta oligomer epitope specific for toxic assemblages in Alzheimer's disease

Alzheimer's & dementia, 2015-07, Vol.11 (7S_Part_3), p.P136-P137

2015

Volltextzugriff (PDF)

P4‐314: Epitope‐specific amyloid‐β oligomer vaccination ameliorates amygdala‐dependent memory deficits and inhibits region‐to‐region spread of plaque pathology in APP/PS1 mice

Alzheimer's & dementia, 2015-07, Vol.11 (7S_Part_19), p.P904-P905

2015

Volltextzugriff (PDF)

Characterization of IXINITY[R]

Advances in Hematology, 2016-01

2016

Volltextzugriff (PDF)

P4‐371: PRECLINICAL DEVELOPMENT OF AN AMYLOID‐B OLIGMER (ABO) SPECIFIC MONOCLONAL ANTIBODY (5E3) FOR POTENTIAL PASSIVE IMMUNOTHERAPY OF ALZHEIMER'S DISEASE

Alzheimer's & dementia, 2014-07, Vol.10 (4S_Part_16), p.P924-P924

2014

Volltextzugriff (PDF)

P2‐397: MICE IMMUNIZED WITH CYCLIC‐SER‐ASN‐LYS (CSNK) PEPTIDE GENERATE POLYCLONAL ANTIBODIES SELECTIVE FOR Aβ OLIGOMERS: A VACCINE STRATEGY FOR ALZHEIMER'S DISEASE

Alzheimer's & dementia, 2014-07, Vol.10 (4S_Part_17), p.P624-P624

2014

Volltextzugriff (PDF)

O4‐04‐01: Characterization of a humanized amyloid beta oligomer monoclonal antibody (5E3) under preclinical development for passive immunotherapy of Alzheimer's disease

Alzheimer's & dementia, 2015-07, Vol.11 (7S_Part_6), p.P275-P275

2015

Volltextzugriff (PDF)

An amyloid-beta oligomer epitope specific for toxic assemblages in Alzheimer’s disease

Alzheimer's & dementia, 2015-07, Vol.11 (7), p.P136-P137

2015

Volltextzugriff (PDF)

Epitope-specific amyloid-β oligomer vaccination ameliorates amygdala-dependent memory deficits and inhibits region-to-region spread of plaque pathology in APP/PS1 mice

Alzheimer's & dementia, 2015-07, Vol.11 (7), p.P904-P905

2015

Volltextzugriff (PDF)

P1‐228: Naturally occurring human antibodies to misfolded Aβ epitope associated with Alzheimer's disease

Alzheimer's & dementia, 2012-07, Vol.8 (4S_Part_5), p.P187-P187

2012

Volltextzugriff (PDF)

Naturally occurring human antibodies to misfolded Aβ epitope associated with Alzheimer's disease

Alzheimer's & dementia, 2012-07, Vol.8 (4), p.P187-P187

2012

Volltextzugriff (PDF)

MICE IMMUNIZED WITH CYCLIC-SER-ASN-LYS (CSNK) PEPTIDE GENERATE POLYCLONAL ANTIBODIES SELECTIVE FOR Aβ OLIGOMERS: A VACCINE STRATEGY FOR ALZHEIMER'S DISEASE

Alzheimer's & dementia, 2014-07, Vol.10 (4), p.P624-P624

2014

Volltextzugriff (PDF)

PRECLINICAL DEVELOPMENT OF AN AMYLOID-B OLIGMER (ABO) SPECIFIC MONOCLONAL ANTIBODY (5E3) FOR POTENTIAL PASSIVE IMMUNOTHERAPY OF ALZHEIMER'S DISEASE

Alzheimer's & dementia, 2014-07, Vol.10 (4), p.P924-P924

2014

Volltextzugriff (PDF)

Normal healthy donors possess plasma IgG reactive to a neutralizing epitope for toxic and amyloid-seeding beta-amyloid oligomers

Alzheimer's & dementia, 2013-07, Vol.9 (4), p.P810-P810

2013

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(38)
Dissertationen
(1)

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Polyclonal hyper immunoglobulin: A proven treatment and prophylaxis platform for passive immunization to address existing and emerging diseases

Mature Pseudomonas aeruginosa Biofilms Prevail Compared to Young Biofilms in the Presence of Ceftazidime

A novel in vitro co-culture system allows the concurrent analysis of mature biofilm and planktonic bacteria with human lung epithelia

Novel Clostridium difficile Anti-Toxin (TcdA and TcdB) Humanized Monoclonal Antibodies Demonstrate In Vitro Neutralization across a Broad Spectrum of Clinical Strains and In Vivo Potency in a Hamster Spore Challenge Model

Characterization of IXINITY^® (Trenonacog Alfa), a Recombinant Factor IX with Primary Sequence Corresponding to the Threonine-148 Polymorph

Angiotensin II Activates Phosphatidylinositol 3-Kinase in Vascular Smooth Muscle Cells

Modulation of the Local Neutrophil Response by a Novel Hyaluronic Acid-Binding Peptide Reduces Bacterial Burden during Staphylococcal Wound Infection

Meta-iodobenzylguanidine, an inhibitor of arginine-dependent mono(ADP-ribosyl)ation, prevents neointimal hyperplasia

Both AT₁ and AT₂ receptors mediate proliferation and migration of porcine vascular smooth muscle cells

Both AT^sub 1^ and AT^sub 2^ receptors mediate proliferation and migration of porcine vascular smooth muscle cells

Both AT 1 and AT 2 receptors mediate proliferation and migration of porcine vascular smooth muscle cells

Both AT1 and AT2 receptors mediate proliferation and migration of porcine vascular smooth muscle cells

O1‐05‐04: An amyloid‐beta oligomer epitope specific for toxic assemblages in Alzheimer's disease

P4‐314: Epitope‐specific amyloid‐β oligomer vaccination ameliorates amygdala‐dependent memory deficits and inhibits region‐to‐region spread of plaque pathology in APP/PS1 mice

Characterization of IXINITY[R]

P4‐371: PRECLINICAL DEVELOPMENT OF AN AMYLOID‐B OLIGMER (ABO) SPECIFIC MONOCLONAL ANTIBODY (5E3) FOR POTENTIAL PASSIVE IMMUNOTHERAPY OF ALZHEIMER'S DISEASE

P2‐397: MICE IMMUNIZED WITH CYCLIC‐SER‐ASN‐LYS (CSNK) PEPTIDE GENERATE POLYCLONAL ANTIBODIES SELECTIVE FOR Aβ OLIGOMERS: A VACCINE STRATEGY FOR ALZHEIMER'S DISEASE

O4‐04‐01: Characterization of a humanized amyloid beta oligomer monoclonal antibody (5E3) under preclinical development for passive immunotherapy of Alzheimer's disease

An amyloid-beta oligomer epitope specific for toxic assemblages in Alzheimer’s disease

Epitope-specific amyloid-β oligomer vaccination ameliorates amygdala-dependent memory deficits and inhibits region-to-region spread of plaque pathology in APP/PS1 mice

P1‐228: Naturally occurring human antibodies to misfolded Aβ epitope associated with Alzheimer's disease

Naturally occurring human antibodies to misfolded Aβ epitope associated with Alzheimer's disease

MICE IMMUNIZED WITH CYCLIC-SER-ASN-LYS (CSNK) PEPTIDE GENERATE POLYCLONAL ANTIBODIES SELECTIVE FOR Aβ OLIGOMERS: A VACCINE STRATEGY FOR ALZHEIMER'S DISEASE

PRECLINICAL DEVELOPMENT OF AN AMYLOID-B OLIGMER (ABO) SPECIFIC MONOCLONAL ANTIBODY (5E3) FOR POTENTIAL PASSIVE IMMUNOTHERAPY OF ALZHEIMER'S DISEASE

Normal healthy donors possess plasma IgG reactive to a neutralizing epitope for toxic and amyloid-seeding beta-amyloid oligomers

Suchergebnisse filtern